MAFLD is now the leading cause of increased GGT and ALT.[25] In our study, GGT was significantly higher in patients with psoriasis than in the nonpsoriasis population, whereas no significant difference in GGT existed between patients with severe psoriasis and those with mild-to-moderate psoriasis. The gene discussed is GPT; the disease is psoriasis.